Article Text

PDF
Two year experience of a catheter-free, radio telemetric, oesophageal pH-monitoring (Bravo®) system in children at a single UK tertiary centre
  1. N Rao,
  2. DI Campbell,
  3. P Narula,
  4. C Taylor,
  5. M Thomson,
  6. P Rao
  1. Centre for Paediatric Gastroenterology, Sheffield Children's Hospital, Sheffield, UK

Abstract

Background Introducing a catheterless form of oesophageal ph-monitoring to a younger or more challenging child has now become possible. The BRAVO® pH-system is a significant advancement in the evaluation of patients with gastroesophageal reflux because of better tolerability.

Aims To evaluate performance, tolerability, safety and day-to-day variability in acid reflux patterns in using the BRAVO® pH-system.

Methods Retrospective review of database and case notes of all children that underwent BRAVO® pH-capsule placement from June'09 to August'11 was done. All the capsules were deployed 4-6 cm proximal to the Z-line of the oesophagus under the influence of general-anaesthesia and under endoscopic vision. The data from the capsules were recorded by radio-telemetry onto the pH-boxes and uploaded onto a computer designated for this purpose. The paired-t-test was used to analyse the pH-values from 2 sub-groups (group 1 with 24 hour recordings and group 2 with 48 hour recordings).

Results 203 consecutive patients (122 male) of median age 9 (2-18 years) had the procedure. The youngest child weighed 9.29 kg. Successful pH data over 24 hours was obtained in 93.6% of patients and over 48 hrs in 59% of patients. Commonest indications were reflux symptoms (45%), abdominal pain (33%) and regurgitation (19.5%). In 12% of our patients with an underlying behaviour disorder the wireless pH study was preferred over a standard naso-oesophageal probe for compliance reasons. The other common indication in our centre was assessment of pre and post fundoplication, with 7 of the results indicating need for surgical management (3 laparoscopic and 4 endoscopic full thickness fundoplication). Nearly all studies (86%) were performed off acid-suppressing medications.

A failure rate of 6.4%(13/203) was noted. Of the 13, 4 failed to detach from the introducer, 8 capsules detached within 1 hour of deployment and other failed due to recording-box error.

There was no statistical difference between the pH-measurements of the first 24 hours with the 48-hour measurements (p=0.56).

No adverse events were noted in any of our patients.

Conclusions The BRAVO® pH system is a safe and effective method of recording oesophageal acid exposure. It is an acceptable alternative for children who are particularly unwilling or unable to tolerate nasopharyngeal pH-catheter. Our results support the use of pH measurement for a period of 24 hours only.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.